Treatment Response Evaluation using (18)F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

PURPOSE: This study compares the value of 3,4-dihydroxy-6-[(18)F]-fluoro-L-phenylalanine ((18)F-FDOPA) PET and MRI in assessing outcome during antiangiogenic treatment in patients with recurrent high-grade gliomas. EXPERIMENTAL DESIGN: Thirty patients were prospectively studied with (18)F-FDOPA PET...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy F., Ellingson, Benjamin M., Pope, Whitney B., Grogan, Tristan, Elashoff, David, Geist, Cheri, Silverman, Daniel H S, Phelps, Michael E., Chen, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079729/
https://ncbi.nlm.nih.gov/pubmed/24687922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1440
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller